Hair loss risk goes up on GLP-1 drugs, BMJ study finds

The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients using other diabetes drugs such as SGLT-2 and DPP-4.